Ezaki Glico Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2024/02/13 | ¥11.26 | ¥17.94 | +59.3% |
| 2023/11/02 | ¥58.76 | ¥81.38 | +38.5% |
| 2023/08/03 | ¥35.78 | ¥56.41 | +57.7% |
| 2023/05/08 | ¥35.46 | ¥66.52 | +87.6% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
MFS SERIES TRUST X-MFS International Intrinsic Value Fund
|
2.2M | -13.81% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
749.2K | +0.93% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
510.8K | +4.01% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
365.0K | 0.00% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
233.9K | 0.00% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
188.9K | -0.21% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥45 | -52.6% |
| 2025 | ¥95 | +5.6% |
| 2024 | ¥90 | +12.5% |
| 2023 | ¥80 | 0.0% |
| 2022 | ¥80 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥338,571M | ¥303,921M | ¥332,590M | ¥331,129M |
| Gross Profit | ¥158,033M | ¥110,749M | ¥123,850M | ¥127,668M |
| Operating Income | ¥19,314M | ¥12,852M | ¥18,626M | ¥11,070M |
| Pretax Income | ¥20,843M | ¥14,032M | ¥20,036M | ¥12,304M |
| Net Income | ¥13,519M | ¥8,099M | ¥14,133M | ¥8,113M |
| EPS | ¥208.44 | ¥126.59 | ¥222.25 | ¥127.53 |
| Operating Margin | 5.70% | 4.23% | 5.60% | 3.34% |
| Balance Sheet | ||||
| Total Assets | ¥356,745M | ¥369,056M | ¥395,743M | ¥377,771M |
| Total Equity | ¥240,790M | ¥244,290M | ¥262,542M | ¥272,004M |
| Total Liabilities | ¥115,955M | ¥124,766M | ¥133,201M | ¥105,767M |
| Cash | ¥102,026M | ¥91,705M | ¥97,199M | ¥60,243M |
| Interest-bearing Debt | ¥30,353M | ¥30,023M | ¥30,001M | ¥165M |
| Equity Ratio | 67.50% | 66.19% | 66.34% | 72.00% |
| D/E Ratio | 0.13 | 0.12 | 0.11 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥28,651M | ¥16,802M | ¥28,063M | ¥1,812M |
| Investing CF | -¥29,194M | -¥20,140M | -¥8,613M | -¥10,255M |
| Financing CF | -¥4,859M | -¥10,284M | -¥6,179M | -¥39,246M |
| Free CF | ¥4,887M | -¥8,895M | ¥9,686M | -¥15,663M |
| Efficiency | ||||
| ROE | 5.61% | 3.32% | 5.38% | 2.98% |
| ROA | 3.79% | 2.19% | 3.57% | 2.15% |
Latest IR Information
-
Notice regarding the status of share buyback
Acquisition period 2026/7/1-2026/7/31: 872,500 ordinary shares acquired through market purchases for a total of 4,546,820,200 yen. In prior board resolutions, the upper limit was 4,600,000 shares and 25,000,000,000 yen, for the period 2026/3/1-2026/12/30, with cumulative acquisitions of 3,221,700 shares for...
Read more -
Notice on Revision of Full-Year Consolidated Earnings Forecast
Full-year consolidated earnings forecast for the fiscal year ending December 2026 is revised upward for net sales to 390,000 million yen from the previous forecast by +10,000 million yen, while operating income is revised downward by 2,000 million yen, ordinary...
Read more -
Ezaki Glico Co., Ltd. Q2 Financial Results Summary (Japanese GAAP) (Consolidated)
Announces the consolidated financial results for the second quarter of the fiscal year ending December 2026 (Japanese GAAP). Revenue was 164,495 million yen, operating income 3,259 million yen, ordinary income 5,506 million yen, and net income attributable to owners of...
Read more -
Notice Regarding Share Buyback
Acquisition period: June 1, 2026 to June 30, 2026; total shares acquired: 563,500 shares; total acquisition amount: 3,020,314,300 yen via market purchases. The cap is 4,600,000 shares (7.23% of issued shares); period from March 1, 2026 to December 30, 2026....
Read more -
Notice of Share Buyback | June 2026
Ezaki Glico acquired 669,900 shares of common stock through market purchases from May 1 to May 31, 2026, totaling 3,683,556,900 yen. The cumulative total of previously acquired shares is 1,785,700 shares, with a total amount of 10,353,244,700 yen. The company...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥4,100
Rating Score: 4.50 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Ezaki Glico Co., Ltd., together with its subsidiaries, produces and sells confectionery, health and food, dairy products, and food ingredients in Japan, China, Southeast Asia, the United States, and internationally. It operates through six segments: Health and Food Business; Dairy Business; Nutritional Confectionery Business; Food Ingredients Business; Other Domestic Business; and Overseas Business. The company produces and sells health-related products, retort food, ice cream, milk, dairy products, western confectioneries, chocolate, biscuits, wheat protein, modified starch, coloring, fine chemical materials and others. It also provides baby formula and processed foods. It sells its products in offices and stores, as well as through e-commerce. Ezaki Glico Co., Ltd. was founded in 1922 and is headquartered in Osaka, Japan.
